Halda Therapeutics was a clinical-stage biotechnology company and Yale University spinout developing oral, targeted cancer therapies built on its proprietary RIPTAC (Regulated Induced Proximity TArgeting Chimera) platform, a novel "hold and kill" modality for the precision treatment of solid tumors. - View it on GitHub